Vivo Bio Tech Current Share Price | Vivo Bio Tech Stock Screener
VIVOBIOT
Biotechnology
Vivo Bio Tech Current Stock Price Today
Live Share Price NSE
₹17.13
▲
0.07 (0.41%)
Live Share Price BSE
₹17.26
▲
0.27 (1.59%)
As of October 1, 2026, the live Vivo Bio Tech share price (NSE: VIVOBIOT) is ₹17.13 on NSE and ₹17.26 on BSE, up 0.41% from the previous close, with shares trading between ₹16.50 and ₹17.99 in today's trading session, and a 52-week range of ₹16.08–₹19.68.
Check Vivo Bio Tech yearly highs lows for the annual price range and momentum.
Use the Vivo Bio Tech stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Vivo Bio Tech Market Cap
₹38.01 Cr.
VIVOBIOT P/E Ratio (TTM)
-13.17
Vivo Bio Tech P/B Ratio
0.41
EPS (TTM)
₹-0.82
Dividend Yield
-
Debt to Equity
0.71
VIVOBIOT 52 Week High
₹19.68
Vivo Bio Tech 52 Week Low
₹16.08
Operating Margin
31.00%
Profit Margin
-35.71%
VIVOBIOT Revenue (TTM)
₹14.00
EBITDA
₹5.00
Net Income
₹-5.00
Total Assets
₹178.00
Total Equity
₹93.00
Vivo Bio Tech Current Share Price Chart
Track the current Vivo Bio Tech share price and stock price with an interactive chart. Analyse VIVOBIOT price trends, trading volume, historical performance, and volatility across different timeframes — the complete Vivo Bio Tech stock quote in one place.
Vivo Bio Tech Company Profile - Fundamental Screener
Screen Vivo Bio Tech company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for VIVOBIOT shares.
Sector
Healthcare
Industry
Biotechnology
Sub-Sector
Biotechnology
Segment
E
ISIN
INE380K01017
Vivo Bio Tech Balance Sheet Screener
Screen VIVOBIOT balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 178 | 143 | 137 | 123 | 123 | 80 | 64 | 55 | 60 | 51 |
| Current Assets | 28 | 42 | 47 | 32 | 26 | 27 | 27 | 25 | 28 | 20 |
| Fixed Assets | 123 | 88 | 80 | 89 | 95 | 52 | 35 | 30 | 28 | 29 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 55 | 38 | 45 | 46 | 52 | 15 | 10 | 9 | 15 | 22 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 93 | 78 | 54 | 52 | 47 | 43 | 33 | 27 | 19 | 13 |
| Share Capital | 22 | 17 | 15 | 15 | 14 | 13 | 13 | 12 | 10 | 9 |
| Reserves & Surplus | 69 | 54 | 40 | 37 | 32 | 28 | 20 | 15 | 7 | 3 |
Vivo Bio Tech Income Statement Screener - Profit & Revenue Analysis
Screen Vivo Bio Tech income statement and profit fundamentals.
Analyze VIVOBIOT quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Vivo Bio Tech share price evaluation.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 14 | 14 | 12 | 13 | 13 | 14 | 12 | 10 | 17 | 12 | 15 | 12 | 9 | 13 | 15 |
| Expenses | 10 | 9 | 7 | 7 | 8 | 8 | 6 | 6 | 6 | 7 | 8 | 7 | 4 | 7 | 14 |
| EBITDA | 5 | 5 | 5 | 6 | 6 | 6 | 5 | 4 | 10 | 6 | 7 | 5 | 5 | 6 | 2 |
| Operating Profit % | 31.00% | 35.00% | 41.00% | 44.00% | 41.00% | 41.00% | 46.00% | 43.00% | 47.00% | 45.00% | 48.00% | 39.00% | 52.00% | 50.00% | 11.00% |
| Depreciation | 3 | 4 | 2 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Interest | 2 | 1 | 2 | 2 | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 |
| Profit Before Tax | 0 | 0 | 1 | 2 | 2 | 2 | 1 | 0 | 6 | 2 | 3 | 0 | 1 | 2 | -2 |
| Tax | 5 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 1 | -1 |
| Net Profit | -5 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 5 | 1 | 2 | 0 | 0 | 1 | -1 |
| EPS | -2.52 | 0.08 | 0.69 | 0.74 | 0.45 | 0.56 | 0.50 | 0.11 | 3.51 | 0.55 | 1.38 | 0.10 | 0.22 | 0.89 | -0.49 |
Vivo Bio Tech Cash Flow Screener - Liquidity Fundamentals
Screen VIVOBIOT cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 35 | 12 | 16 | 15 | 17 | 14 | 9 | -1 | 11 | -6 |
| Investing Activities | -59 | -16 | -8 | -4 | -51 | -23 | -10 | -4 | -5 | -12 |
| Financing Activities | 25 | 4 | -8 | -11 | 35 | 9 | 2 | 1 | -3 | 7 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 1 | 0 | 1 | -4 | 3 | -11 |
Vivo Bio Tech Shareholding Pattern Screener
See Vivo Bio Tech shareholding pattern with promoter, FII, and DII holdings.
Check Vivo Bio Tech promoter holding and ownership changes for VIVOBIOT on TickJournal.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Apr | 2025-May | 2025-Jun | 2025-Aug | 2025-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 35.43% | 30.62% | 40.85% | 43.36% | 42.29% | 39.06% | 36.43% | 35.16% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 32.37% | 32.52% | 34.74% | 33.27% | 35.48% | 34.39% | 33.48% | 32.30% |
| Other Holding | 32.20% | 36.87% | 24.41% | 23.37% | 22.23% | 26.55% | 30.09% | 32.53% |
| Shareholder Count | 21,427 | 21,224 | 21,169 | 21,935 | 21,909 | 21,896 | 21,890 | 21,659 |
Vivo Bio Tech Share Dividend Screener - Share Yield Analysis
Check Vivo Bio Tech dividend history with payout and yield data.
View Vivo Bio Tech dividend details including ex-dates and amounts for VIVOBIOT stock.
Vivo Bio Tech Stock Index Membership
See which indices include Vivo Bio Tech stock.
Check VIVOBIOT index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Vivo Bio Tech Market Events Screener - Corporate Actions
Get Vivo Bio Tech corporate actions including splits, bonuses, and buybacks.
Check Vivo Bio Tech stock events that may affect VIVOBIOT share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-30 | 2026-09-30 | Annual General Meeting | NA | -13.78% |
| 2026-07-13 | 2026-07-13 | Quarterly Result Announcement | NA | 0.86% |
| 2026-05-30 | 2026-05-30 | Quarterly Result Announcement | NA | 1.77% |
| 2026-02-13 | 2026-02-13 | Quarterly Result Announcement | NA | 0.46% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | 1.46% |
| 2025-09-30 | 2025-09-30 | Annual General Meeting | NA | -1.59% |
| 2025-08-12 | 2025-08-12 | Quarterly Result Announcement | NA | 13.72% |
| 2025-05-19 | 2025-05-19 | Quarterly Result Announcement | NA | 3.47% |
| 2025-02-07 | 2025-02-07 | Extraordinary General Meeting | NA | -8.43% |
| 2025-01-09 | 2025-01-09 | Quarterly Result Announcement | NA | 27.98% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -5.94% |
| 2024-09-30 | 2024-09-30 | Annual General Meeting | NA | 0.96% |
Vivo Bio Tech Competitors Screener - Peer Comparison
Screen VIVOBIOT competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Anthem Biosciences | 48,224 | 83.88 | 2,280 | 18.12% | 592 | 39.50 |
| Advanced Enzyme Tech | 3,048 | 18.30 | 781 | 16.51% | 174 | 28.77 |
| CCME Global | 188 | -229.95 | 4 | % | 0 | 43.71 |
| Vivo Bio Tech | 38 | -13.17 | 54 | 4.47% | -2 | 44.21 |
| Shree Ganesh Bio-Tech | 19 | -47.00 | 6 | -73.77% | 0 | 40.94 |
| Genomic Valley Biotech | 9 | 434.14 | 0 | -66.25% | 0 | 46.78 |
Vivo Bio Tech Company Announcements - News Screener
Screen VIVOBIOT latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-10-01 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-10-01 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-10-01 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-09-26 | Closure of Trading Window | - |
| 2026-09-10 | Re-Lodgement Of Transfer Requests Of Physical Shares. | - |
| 2026-09-09 | Web Link Intimation | - |
| 2026-09-09 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-08 | Reg. 34 (1) Annual Report. | - |
| 2026-09-08 | 39Th Annual General Meeting Notice. | - |
| 2026-08-26 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-24 | Expiry Of Warrants | - |
| 2026-08-24 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-08-24 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-08-24 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-08-22 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-08-22 | Board Meeting Outcome for Outcome Of Board Meeting | - |
| 2026-08-21 | Expiry Of Warrants | - |
| 2026-08-20 | Expiry Of Warrants | - |
| 2026-07-15 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-07-14 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | - |